BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $698,605 | +84374.6% | 18,511 | +1.9% | 0.05% | -12.9% |
| Q2 2023 | $827 | +13.6% | 18,159 | +1.1% | 0.06% | +3.3% |
| Q1 2023 | $728 | -20.9% | 17,957 | -0.5% | 0.06% | -25.0% |
| Q4 2022 | $920 | -99.9% | 18,048 | 0.0% | 0.08% | -11.1% |
| Q3 2022 | $972,000 | -12.0% | 18,048 | +4.9% | 0.09% | -10.9% |
| Q2 2022 | $1,105,000 | -3.6% | 17,203 | +16.4% | 0.10% | 0.0% |
| Q1 2022 | $1,146,000 | +0.8% | 14,779 | +11.6% | 0.10% | -4.7% |
| Q4 2021 | $1,137,000 | +11.5% | 13,241 | +4.4% | 0.11% | -1.9% |
| Q3 2021 | $1,020,000 | -3.2% | 12,678 | -3.1% | 0.11% | -3.6% |
| Q2 2021 | $1,054,000 | -8.3% | 13,088 | -4.0% | 0.11% | -8.9% |
| Q1 2021 | $1,150,000 | +0.7% | 13,631 | -4.2% | 0.12% | -5.4% |
| Q4 2020 | $1,142,000 | +6.9% | 14,236 | +7.2% | 0.13% | -12.2% |
| Q3 2020 | $1,068,000 | -0.9% | 13,280 | +6.1% | 0.15% | -14.9% |
| Q2 2020 | $1,078,000 | -14.2% | 12,515 | -19.1% | 0.17% | -11.2% |
| Q1 2020 | $1,256,000 | +24.2% | 15,476 | +28.0% | 0.20% | +21.0% |
| Q4 2019 | $1,011,000 | -4.1% | 12,093 | +0.4% | 0.16% | -12.4% |
| Q3 2019 | $1,054,000 | +30.1% | 12,045 | +21.7% | 0.18% | +13.5% |
| Q2 2019 | $810,000 | +5.1% | 9,895 | +4.4% | 0.16% | -3.6% |
| Q1 2019 | $771,000 | +19.7% | 9,477 | -3.2% | 0.17% | +5.0% |
| Q4 2018 | $644,000 | -11.0% | 9,789 | +4.3% | 0.16% | +0.6% |
| Q3 2018 | $724,000 | +5.7% | 9,386 | +1.2% | 0.16% | -2.4% |
| Q2 2018 | $685,000 | -7.4% | 9,278 | -18.4% | 0.16% | +12.3% |
| Q1 2018 | $740,000 | -14.0% | 11,376 | -14.5% | 0.15% | +2.1% |
| Q4 2017 | $860,000 | +6.3% | 13,312 | +3.2% | 0.14% | 0.0% |
| Q3 2017 | $809,000 | 0.0% | 12,898 | -3.4% | 0.14% | -0.7% |
| Q2 2017 | $809,000 | +18.6% | 13,358 | +1.6% | 0.14% | +14.3% |
| Q1 2017 | $682,000 | -3.0% | 13,143 | -17.1% | 0.13% | +10.5% |
| Q4 2016 | $703,000 | -16.1% | 15,849 | -10.0% | 0.11% | -14.3% |
| Q3 2016 | $838,000 | -16.9% | 17,601 | -21.1% | 0.13% | -3.6% |
| Q2 2016 | $1,008,000 | -1.0% | 22,299 | -10.1% | 0.14% | +9.5% |
| Q1 2016 | $1,018,000 | +30.2% | 24,791 | +21.0% | 0.13% | +7.7% |
| Q4 2015 | $782,000 | +30.6% | 20,489 | +12.4% | 0.12% | +9.3% |
| Q3 2015 | $599,000 | -51.8% | 18,228 | +2.7% | 0.11% | -49.3% |
| Q2 2015 | $1,242,000 | +3.9% | 17,754 | +1.8% | 0.21% | +2.9% |
| Q1 2015 | $1,195,000 | -15.3% | 17,444 | -9.4% | 0.20% | -6.4% |
| Q4 2014 | $1,411,000 | +5.5% | 19,259 | +0.2% | 0.22% | -5.2% |
| Q3 2014 | $1,337,000 | -3.2% | 19,218 | +0.6% | 0.23% | +1.8% |
| Q2 2014 | $1,381,000 | +0.2% | 19,106 | +2.0% | 0.23% | -6.2% |
| Q1 2014 | $1,378,000 | +3.1% | 18,727 | -2.6% | 0.24% | +4.8% |
| Q4 2013 | $1,337,000 | +5.3% | 19,218 | -0.6% | 0.23% | -4.5% |
| Q3 2013 | $1,270,000 | – | 19,338 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |